Cardiovascular surgeons employ myocardial revascularization as a vital therapeutic strategy for individuals grappling with coronary artery disease, a prevalent cardiovascular affliction. The primary objective of this medical intervention is to reinstate optimal blood circulation to the heart muscle, mitigating the impact of arterial blockages. Myocardial revascularization encompasses various techniques, including coronary artery bypass grafting and angioplasty, each tailored to address specific intricacies of the arterial blockages. By skillfully navigating through the complexities of the cardiovascular system, surgeons endeavor to alleviate ischemic heart conditions and ameliorate symptoms such as angina. The strategic deployment of bypass grafts or the dilation of narrowed arteries through angioplasty plays a pivotal role in restoring the heart's blood supply. This, in turn, contributes significantly to minimizing chest pain, enhancing overall cardiac function, and ultimately diminishing the likelihood of debilitating heart attacks.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation